BiotechTube
Atlas Antibodies

Atlas Antibodies

Bromma, Sweden· Est.
atlasantibodies.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Atlas Antibodies is a specialized provider of research antibodies and protein analysis tools, spun out from the landmark Human Protein Atlas initiative. Its core value proposition lies in offering exhaustively validated, application-specific antibodies, leveraging its unique heritage and data from the Human Protein Atlas. The company's portfolio includes primary antibodies, recombinant antibodies, control antigens, and innovative multiplexing assays like AtlasPlex and MolBoolean, targeting the global life science research and clinical diagnostics markets. It is a private company, fully owned by Patricia Industries as part of the Atlas Life Sciences Group.

Antibodies

Technology Platform

Antibody generation and validation platform rooted in data from the Human Protein Atlas (HPA). Utilizes Protein Epitope Signature Tags (PrESTs) and recombinant technology to produce specific antibodies. Proprietary multiplex immunoassay (AtlasPlex) and advanced proximity ligation (MolBoolean) platforms for protein analysis.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The growing demand for highly validated, reproducible research reagents presents a major opportunity to differentiate from competitors.
Expansion of multiplex protein analysis tools (AtlasPlex, MolBoolean) addresses the trend towards systems biology and could open doors in clinical diagnostics.
Leveraging the continuous data generation from the Human Protein Atlas allows for ongoing portfolio expansion.

Risk Factors

Heavy reliance on the reputation and continuity of the Human Protein Atlas project creates concentration risk.
The research antibody market is intensely competitive with large, well-capitalized players.
Successful commercialization of newer platform technologies (multiplex assays) requires significant market education and adoption.

Competitive Landscape

Atlas Antibodies competes in the global research antibodies market against giants like Thermo Fisher Scientific, Abcam, and Merck Millipore, as well as numerous niche players. Its primary differentiation is its rigorous, application-specific validation rooted in the Human Protein Atlas and its 'by researchers, for researchers' ethos. In the multiplex assay space, it faces competition from dedicated proteomics and immunoassay companies.

More companies in Sweden →